News

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.
J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.
Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...